Parker Duffney, Ph.D., DABT is a lead risk assessment research scientist in the Center for Informatics and Screening within UL Research Institutes’ Chemical Insights. Parker will be tasked with developing human health risk assessment products for priority chemicals to support the needs of partnering states. He will provide expertise in inhalation toxicology and human health risk assessment methods. 

Parker received his Bachelor of Science in Biochemistry from the State University of New York College at Geneseo and a Masters and Doctorate in Toxicology from the University of Rochester. His dissertation research focused on the impact of inhaled smoke from cigarette smoke and other biomass sources on host defence against viral infection in the lung utilizing in vitro, ex vivo, and in vivo models.  Parker did his postdoc at UNC Chapel Hill where he performed research on the impacts of environmental ozone on pulmonary health. His work included translational research using human clinical samples. 

Prior to joining ULRI, Parker spent 6 years as a Toxicologist at the U.S. Environmental Protection Agency where he led literature review assessment efforts. He also contributed to systematic review efforts and data analysis projects to support agency goals. He has presented his research and risk assessment work in peer-reviewed publications, book chapters, oral presentations, and poster presentations. His research and risk assessment contributions have been recognized through awards from the Society of Toxicology, American Thoracic Society, and U.S. EPA. 

ORCiD: 0000-0002-1042-7417